The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients

Tumor Biology

Volumn 35, Issue 8, 2014, Pages 8259-8265

  Li, Xiang Ping ^a   Yin, Ji Ye ^a   Wang, Ying ^a   He, Hui ^a   Li, Xi ^a   Gong, Wei Jing ^a   Chen, Juan ^a   Qian, Chen Yue ^a   Zheng, Yi ^a   Li, Fang ^a   Yin, Tao ^a   Gong, Zhi Cheng ^a   Zhou, Bo Ting ^a   Zhang, Yu ^a   Xiao, Ling ^a   Zhou, Hong Hao ^a   Liu, Zhao Qian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ATP7B; Chemotherapy; Efficacy; Lung cancer; Platinum; Polymorphism

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CATION TRANSPORT PROTEIN; PLATINUM; WILSON DISEASE PROTEIN;

ADULT; AGED; FEMALE; GENETICS; GENOTYPE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOSINE TRIPHOSPHATASES; ADULT; AGED; CATION TRANSPORT PROTEINS; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLATINUM; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84922393753     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2072-0     Document Type: Article

References (39)

1. Wheate NJ, Walker S, Craig GE, Oun R. The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Trans. 2010;39:8113–27.
2. Stordal B, Davey M. Understanding cisplatin resistance using cellular models. IUBMB life. 2007;59:696–9.
3. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7:573–84.
4. Shahzad MM, Lopez-Berestein G, Sood AK. Novel strategies for reversing platinum resistance. Drug Resist Updat: Rev Commentaries Antimicrob Anticancer Chemother. 2009;12:148–52.
5. La Fontaine S, Mercer JF. Trafficking of the copper-atpases, atp7a and atp7b: Role in copper homeostasis. Arch Biochem Biophys. 2007;463:149–67.
6. Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T, et al. Copper-transporting p-type adenosine triphosphatase (atp7b) is associated with cisplatin resistance. Cancer Res. 2000;60:1312–6.
7. Terada K, Schilsky ML, Miura N, Sugiyama T. Atp7b (wnd) protein. Int J Biochem Cell Biol. 1998;30:1063–7.
8. Harris ED, Qian Y, Tiffany-Castiglioni E, Lacy AR, Reddy MC. Functional analysis of copper homeostasis in cell culture models: a new perspective on internal copper transport. Am J Clin Nutr. 1998;67:988S–95.
9. Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev. 2007;26:71–83.
10. Safaei R. Role of copper transporters in the uptake and efflux of platinum containing drugs. Cancer Lett. 2006;234:34–9.
11. Katano K, Safaei R, Samimi G, Holzer A, Rochdi M, Howell SB. The copper export pump atp7b modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol Pharmacol. 2003;64:466–73.
12. Samimi G, Katano K, Holzer AK, Safaei R, Howell SB. Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters atp7a and atp7b. Mol Pharmacol. 2004;66:25–32.
13. Nakayama K, Kanzaki A, Terada K, Mutoh M, Ogawa K, Sugiyama T, et al. Prognostic value of the cu-transporting atpase in ovarian carcinoma patients receiving cisplatin-based chemotherapy. Clin Cancer Res: Off J Am Assoc Cancer Res. 2004;10:2804–11.
14. Aida T, Takebayashi Y, Shimizu T, Okamura C, Higasimoto M, Kanzaki A, et al. Expression of copper-transporting p-type adenosine triphosphatase (atp7b) as a prognostic factor in human endometrial carcinoma. Gynecol Oncol. 2005;97:41–5.
15. Leslie EM, Letourneau IJ, Deeley RG, Cole SP. Functional and structural consequences of cysteine substitutions in the nh2 proximal region of the human multidrug resistance protein 1 (mrp1/abcc1). Biochemistry. 2003;42:5214–24.
16. Yin JY, Huang Q, Yang Y, Zhang JT, Zhong MZ, Zhou HH, et al. Characterization and analyses of multidrug resistance-associated protein 1 (mrp1/abcc1) polymorphisms in Chinese population. Pharmacogenet Genomics. 2009;19:206–16.
17. Pasanen MK, Neuvonen PJ, Niemi M. Global analysis of genetic variation in slco1b1. Pharmacogenomics. 2008;9:19–33.
18. Xu X, Ren H, Zhou B, Zhao Y, Yuan R, Ma R, et al. Prediction of copper transport protein 1 (ctr1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (nsclc) patients. Lung Cancer (Amsterdam, Netherlands). 2012;77:438–42.
19. Xu X, Duan L, Zhou B, Ma R, Zhou H, Liu Z. Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients. Clin Exp Pharmacol Physiol. 2012;39:786–92.
20. Fukushima-Uesaka H, Saito Y, Maekawa K, Kurose K, Sugiyama E, Katori N, et al. Genetic polymorphisms of copper- and platinum drug-efflux transporters atp7a and atp7b in Japanese cancer patients. Drug Metab Pharmacokinet. 2009;24:565–74.
21. Panichareon B, Taweechue K, Thongnoppakhun W, Aksornworanart M, Pithukpakorn M, Yenchitsomanus PT, et al. Six novel atp7b mutations in Thai patients with Wilson disease. Eur J Med Gen. 2011;54:103–7.
22. Ettinger D, Johnson B. Update: Nccn small cell and non-small cell lung cancer clinical practice guidelines. J Natl Compr Cancer Netw: JNCCN. 2005;3 Suppl 1:S17–21.
23. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–16.
24. Barrett JC: Haploview: Visualization and analysis of snp genotype data. Cold Spring Harbor protocols 2009;2009:pdb ip71
25. Jurinke C, Oeth P, van den Boom D. Maldi-tof mass spectrometry: A versatile tool for high-performance DNA analysis. Mol Biotechnol. 2004;26:147–64.
26. Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting atpases. Physiol Rev. 2007;87:1011–46.
27. Safaei R, Adams PL, Maktabi MH, Mathews RA, Howell SB. The cxxc motifs in the metal binding domains are required for atp7b to mediate resistance to cisplatin. J Inorg Biochem. 2012;110:8–17.
28. Dolgova NV, Olson D, Lutsenko S, Dmitriev OY. The soluble metal-binding domain of the copper transporter atp7b binds and detoxifies cisplatin. Biochem J. 2009;419:51–6. 53 p following 56.
29. Dmitriev OY. Mechanism of tumor resistance to cisplatin mediated by the copper transporter atp7b. Biochem Cell Biol = Biochimie et biologie cellulaire. 2011;89:138–47.
30. Safaei R, Otani S, Larson BJ, Rasmussen ML, Howell SB. Transport of cisplatin by the copper efflux transporter atp7b. Mol Pharmacol. 2008;73:461–8.
31. Katano K, Safaei R, Samimi G, Holzer A, Tomioka M, Goodman M, et al. Confocal microscopic analysis of the interaction between cisplatin and the copper transporter atp7b in human ovarian carcinoma cells. Clin Cancer Res: Off J Am Assoc Cancer Res. 2004;10:4578–88.
32. Leonhardt K, Gebhardt R, Mossner J, Lutsenko S, Huster D. Functional interactions of cu-atpase atp7b with cisplatin and the role of atp7b in the resistance of cells to the drug. J Biol Chem. 2009;284:7793–802.
33. Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet. 2005;42:737–48.
34. Buratti E, Baralle M, Baralle FE. Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res. 2006;34:3494–510.
35. Kim CH, Kim HS, Cubells JF, Kim KS. A previously undescribed intron and extensive 5' upstream sequence, but not phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene. J Biol Chem. 1999;274:6507–18.
36. Klett CP, Bonner TI. Identification and characterization of the rat m1 muscarinic receptor promoter. J Neurochem. 1999;72:900–9.
37. Wu ZY, Wang N, Lin MT, Fang L, Murong SX, Yu L. Mutation analysis and the correlation between genotype and phenotype of arg778leu mutation in Chinese patients with Wilson disease. Arch Neurol. 2001;58:971–6.
38. Bucossi S, Polimanti R, Mariani S, Ventriglia M, Bonvicini C, Migliore S, et al. Association of k832r and r952k snps of Wilson's disease gene with Alzheimer's disease. J Alzheimer’s Dis: JAD. 2012;29:913–9.
39. Schmid SC, Schuster T, Horn T, Gschwend J, Treiber U, Weirich G. Utility of atp7b in prediction of response to platinum-based chemotherapy in urothelial bladder cancer. Anticancer Res. 2013;33:3731–7.